C5E:PA:PA-Amundi Stoxx Europe 50 UCITS (EUR)

ETF | Others |

Last Closing

USD 119.32

Change

0.00 (0.00)%

Market Cap

USD 0.57B

Volume

3.86K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.43 (+0.97%)

USD 56.03B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+13.50 (+2.78%)

USD 13.60B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+9.94 (+2.85%)

USD 11.29B
WRD:PA HSBC MSCI World UCITS ETF

+0.81 (+2.51%)

USD 11.04B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+4.60 (+1.84%)

USD 10.45B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+16.10 (+3.86%)

USD 8.68B
WLD:PA Lyxor UCITS MSCI World D-EUR

+7.96 (+2.50%)

USD 7.49B
HHH:PA HSBC S&P 500 UCITS ETF

+1.39 (+2.84%)

USD 7.22B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

+0.27 (+4.42%)

USD 6.16B
SPY4:PA SSgA SPDR S&P 400 US Mid Cap

+2.33 (+3.04%)

USD 5.38B

ETFs Containing C5E:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.49% 77% C+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.49% 77% C+ 67% D+
Trailing 12 Months  
Capital Gain 3.36% 45% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.36% 39% F 55% F
Trailing 5 Years  
Capital Gain 76.90% 70% C- 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 76.90% 66% D+ 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 13.10% 75% C 75% C
Dividend Return 13.10% 73% C 73% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.89% 74% C 86% B+
Risk Adjusted Return 166.11% 99% N/A 99% N/A
Market Capitalization 0.57B 67% D+ 70% C-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike